Brokerages Expect Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) to Post -$0.90 Earnings Per Share

Equities research analysts predict that Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) will post ($0.90) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Amylyx Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.96) and the highest is ($0.84). The business is expected to issue its next […]

Related Keywords

United States ,Canada , ,Amylyx Pharmaceuticals ,Amylyx Pharmaceuticals Inc ,Zacks Investment Research ,Amylyx Pharmaceuticals Get Rating ,Citigroup ,Nasdaq ,Get Rating ,Amylyx Pharmaceutical ,Nasdaq Amlx ,Amlx ,Medical ,Ratings ,Consensus ,